Evidence map›Paper›PMID 23905907›Full record

ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2013

Development of food allergies in patients with gastroesophageal reflux disease treated with gastric acid suppressive medications.

Anita Trikha, Jacques G Baillargeon, Yong-fang Kuo, Alai Tan, Karen Pierson, Gulshan Sharma, Gregg Wilkinson, Rana S Bonds

Abstract read
In one paragraph

Article in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Acid-suppressive medication and incidence of chronic childhood immune-mediated diseases: A scoping review.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Stability of allergens.Molecular immunology · 2018
    Review
  14. Environmental factors and eosinophilic esophagitis.The Journal of allergy and clinical immunology · 2018
    Review
  15. Article
  16. Experimental Models for Studying Food Allergy.Cellular and molecular gastroenterology and hepatology · 2018
    Review
  17. Gastro-Esophageal Reflux in Children.International journal of molecular sciences · 2017
    Review
  18. Review
  19. Allergic diseases and asthma in pregnancy, a secondary publication.The World Allergy Organization journal · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anita TrikhaNational Jewish Health, Denver, CO, USA. trikhaa@njhealth.org
Jacques G Baillargeon
Yong-fang Kuo
Alai Tan
Karen Pierson
Gulshan Sharma
Gregg Wilkinson
Rana S Bonds
Galveston College · USThe University of Texas Medical Branch at Galveston · US

Funding

UTMB CLINICAL AND TRANSLATIONAL SCIENCE AWARD: NASA BED REST STUDIESUL1RR029876 · NCRR · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2009 to 2011
$17.7M
UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
UTMB Clinical and Translational Science AwardKL2TR000072 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$422k
NCATS NIH HHS KL2 TR000072NCATS NIH HHS UL1 TR000071NCRR NIH HHS UL1 RR029876NCRR NIH HHS UL1RR029876
6 · The paper itself

Abstract

backgroundThe prevalence of food allergy has steadily increased, especially in children. Reflux disease, a very common problem in children, is often treated with gastric acid suppressive (GAS) medications which may alter the processing of food allergens, thereby affecting oral mucosal tolerance.

objectiveThe purpose of this study was to determine if use of GAS medications is associated with the occurrence of food allergies in children.

methodsUsing a large national commercial insurance database, we identified 4724 children aged 0-18 yrs who were diagnosed with Gastroesophageal Reflux Disease (GERD) and treated with GAS medications between January 1, 2008 and September 30, 2009. We then matched 4724 children with GERD not treated with GAS medications and 4724 children without GERD and not treated with GAS medications, at a 1:1 ratio, on age, gender and number of atopic risk factors. Patients were followed for 12 months.

resultsIn comparison to the referent (children without GERD who received no GAS medications), children with GERD who were treated with GAS were more likely to be diagnosed with a food allergy (Hazard ratio (HR): 3.67, 95% CI 2.15-6.27), as were children with GERD diagnosis but who were not treated with GAS medications (HR: 2.15, 95% CI: 1.21-3.81). A direct comparison of the two GERD cohorts showed that children with GERD who were treated with GAS had a greater risk of food allergy than those with GERD who were untreated (HR, 1.68, 95%CI, 1.15-2.46).

conclusionTreatment with GAS medications is associated with the occurrence of food allergy, an effect not apparently related to a diagnosis of GERD alone.

Indexed as

AntacidsChildChild, PreschoolCohort StudiesFollow-Up StudiesFood HypersensitivityGastric AcidGastroesophageal RefluxHumansImmune ToleranceInfantInfant, NewbornMaleMouth MucosaRiskUnited StatesAntacidsfood allergygastric acid suppressionGastroesophageal Reflux Disease

Identifiers

PMID23905907
PMCPMC4528619
OpenAlexW2146913149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.